Gofen & Glossberg’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-13,000
Closed -$26K 465
2016
Q1
$26K Hold
13,000
﹤0.01% 453
2015
Q4
$32K Hold
13,000
﹤0.01% 441
2015
Q3
$34K Hold
13,000
﹤0.01% 445
2015
Q2
$41K Hold
13,000
﹤0.01% 449
2015
Q1
$37K Hold
13,000
﹤0.01% 456
2014
Q4
$34K Sell
13,000
-1,000
-7% -$4.38K ﹤0.01% 454
2014
Q3
$104K Buy
14,000
+2,000
+17% +$18.7K ﹤0.01% 437
2014
Q2
$141K Buy
12,000
+1,600
+15% +$17.1K 0.01% 431
2014
Q1
$128K Buy
+10,400
New +$122K 0.01% 462

Gofen & Glossberg's SZYM Position: Q2 2016 in Review

Gofen & Glossberg sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 13,000 shares — an estimated $26K sold.

Gofen & Glossberg first reported a position in SZYM in Q1 2014 and held it in 9 quarters. The position peaked at $141K in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Gofen & Glossberg reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Gofen & Glossberg sold 13,000 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $26K.
  • Gofen & Glossberg first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 9 quarters.
  • Gofen & Glossberg's SOLAZYME INC COM STK (DE) position peaked at $141K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Gofen & Glossberg's 13F filing for Q2 2016, filed 13 Jul 2016.